{
    "2021-07-08": [
        [
            {
                "time": "",
                "original_text": "中国CRO沉浮：一场挫败、崛起、狂欢的盛宴",
                "features": {
                    "keywords": [
                        "CRO",
                        "医药",
                        "创新",
                        "分化"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "肿瘤药伪创新遭“敲打”，医药合同外包行业分化加剧",
                "features": {
                    "keywords": [
                        "肿瘤药",
                        "伪创新",
                        "外包",
                        "行业分化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "港股药品股持续下挫，翰森制药跌8.32%，精优药业跌8.21%...",
                "features": {
                    "keywords": [
                        "港股",
                        "药品股",
                        "下挫",
                        "跌幅"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "CDE新政加速医药创新迭代，看好头部药企、Biotech和CXO公司",
                "features": {
                    "keywords": [
                        "CDE新政",
                        "医药创新",
                        "头部药企",
                        "Biotech",
                        "CXO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "港股医药外包概念股继续走低，泰格医药跌近8%，昭衍新药跌7.3%...",
                "features": {
                    "keywords": [
                        "港股",
                        "医药外包",
                        "走低",
                        "跌幅"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "创业板50成份股调整，新增了哪些大明星？",
                "features": {
                    "keywords": [
                        "创业板50",
                        "成份股",
                        "调整",
                        "新增"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "证券"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)跌4.63%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "下跌",
                        "跌幅"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药创新长期高景气，看多龙头公司",
                "features": {
                    "keywords": [
                        "医药创新",
                        "景气",
                        "龙头公司"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "JP Morgan Chase & Co.减持康龙化成股份约97.98万股",
                "features": {
                    "keywords": [
                        "JP Morgan",
                        "减持",
                        "康龙化成",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}